Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Mesothelioma × Radiosurgery × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Brain Neoplasms 20 Carcinoma, Non-Small-Cell Lung 15 Pancreatic Neoplasms 11 Neoplasm Metastasis 10 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 7 Glioblastoma 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Neoplasms 5 Glioma 5 Carcinoma, Hepatocellular 5 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Uveal Melanoma 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Mouth Neoplasms 2 Liver Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Gliosarcoma 2

Interventions

Cisplatin 10 Pemetrexed 9 pembrolizumab 8 Nivolumab 3 budigalimab 2 belinostat 2 Paclitaxel 2 LMB-100 2 Docetaxel 2 Dexamethasone 2 Carboplatin 2 Calcium Dobesilate 2 venetoclax 1 trametinib 1 tislelizumab 1 tazemetostat 1 talazoparib 1 spartalizumab 1 sodium thiosulfate 1 sargramostim 1 rovalpituzumab tesirine 1 olaparib 1 obinutuzumab 1 naptumomab estafenatox 1 irinotecan sucrosofate 1 fludarabine 1 enzalutamide 1 durvalumab 1 cabozantinib 1 bosutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04166734 2026-02-04

MESO-PRIME

Royal Marsden NHS Foundation Trust

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡